Inspectors general
Top drug regulator George Tidmarsh resigned Sunday from the Food and Drug Administration, amid scrutiny over his comments criticizing a treatment made by Aurinia Pharmaceuticals. Tidmarsh had been placed on administrative leave Friday after concerns were raised about his personal conduct. He had been at the FDA since July, overseeing
Inspectors general
Top drug regulator George Tidmarsh resigned Sunday from the Food and Drug Administration, amid scrutiny over his comments criticizing a treatment made by Aurinia Pharmaceuticals. Tidmarsh had been placed on administrative leave Friday after concerns were raised about his personal conduct. He had been at the FDA since July, overseeing
Inspectors general
Top drug regulator George Tidmarsh resigned Sunday from the Food and Drug Administration, amid scrutiny over his comments criticizing a treatment made by Aurinia Pharmaceuticals. Tidmarsh had been placed on administrative leave Friday after concerns were raised about his personal conduct. He had been at the FDA since July, overseeing
Inspectors general
Top drug regulator George Tidmarsh resigned Sunday from the Food and Drug Administration, amid scrutiny over his comments criticizing a treatment made by Aurinia Pharmaceuticals. Tidmarsh had been placed on administrative leave Friday after concerns were raised about his personal conduct. He had been at the FDA since July, overseeing
Inspectors general
Committee Democrats have sent letters to 24 major federal agencies, citing the Trump Administration's efforts to block inspectors general from doing their jobs. Reports to the Committee include general vacancies, staffing shortages, and delayed agency responses to investigation requests. Without adequate resources and information, inspectors general cannot hold
Executive dismissals
President Trump has fired or demoted more than 20 inspectors general since taking office, hobbling offices that serve as a check on waste, fraud, and abuse in government. The move has led to a chilling effect on government accountability, with many employees fearful of pursuing investigations that could prompt political
Insurance industry
Witnesses Neil Barofsky, Thomas C. Baxter, Elias Habayeb, and Stephen Friedman testified before the House Oversight and Government Reform Committee on January 27, 2010, regarding the federal bailout of AIG. In a heated exchange, Representative Edolphus Towns questioned Friedman, a former chairman of the Federal Reserve Bank of New York
Insurance industry
The House Oversight and Government Reform Committee, led by Delegate Eleanor Holmes Norton, convened a hearing on the Federal Bailout of AIG, featuring key witnesses from the Troubled Asset Relief Program (TARP) and AIG. The hearing shed light on critical transactions that facilitated the unwinding of a significant portion of
